Triazole derivatives as tachykinin receptor antagonists
Details for Australian Patent Application No. 2003230829 (hide)
International Classifications
Event Publications
14 August 2003 Complete Application Filed
Priority application(s): 60/376,121 26.04.02 US
18 December 2003 Application Open to Public Inspection
Published as AU-B-2003230829
4 December 2008 Application Accepted
Published as AU-B-2003230829
11 December 2008 Corrigenda
Applications Accepted - Name Index Under the name Eli Lilly and Company, Application No. 2003230829, under INID(72) correct the co-inventor name to Gardinier, Kevin Matthew Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2002354120 The Yokohama Rubber Co., Ltd. 2004201062 The Penn State Research Foundation 2005202046 Bayer Schering Pharma Aktiengesellschaft
2 April 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003230830-TREATMENT OF TYPE 1 DIABETES BEFORE AND AFTER EXPRESSION OF PREDISPOSITION MARKERS
2003230828-SYSTEM FOR RATING CONSTRUCTED RESPONSES BASED ON CONCEPTS AND A MODEL ANSWER
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser